微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 59.49% | -4.57% | -8.86% | 53/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 65.28% | 14.91% | 2.5% | 44/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 63.69% | 19.33% | 2.29% | 50/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 62.26% | 26.21% | -0.13% | 55/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 62.34% | 40.66% | 9.74% | 48/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 56.81% | 5.26% | 6.44% | 63/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 53.37% | -5.3% | 8.18% | 69/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 49.33% | -12.19% | 11.31% | 74/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 44.32% | -31.12% | -17.87% | 82/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 53.97% | -5.06% | -4.24% | 65/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 56.36% | -0.52% | 0.31% | 61/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 56.18% | 1.59% | -12.69% | 68/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 64.34% | 13.94% | 13.19% | 42/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 56.84% | -1.66% | 0.34% | 73/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 56.65% | 2% | 2.44% | 66/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 55.3% | -6.81% | -2.07% | 72/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 56.47% | 2% | -2.3% | 63/131 | 60.75% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 57.8% | 14.04% | -2.6% | 76/131 | 59.59% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 59.34% | 2% | 17.08% | 60/131 | 59.94% | 正海生物 | 92.69% | 行业排名> |
| 2019-12-31 | 50.68% | 28.03% | 28.03% | 70/131 | 56.37% | 正海生物 | 92.61% | 行业排名> |
| 2018-12-31 | 39.59% | 8.07% | 8.07% | 81/131 | 55.53% | 正海生物 | 94.38% | 行业排名> |
| 2017-12-31 | 36.63% | 2% | 2% | 79/131 | 55.34% | 正海生物 | 93.12% | 行业排名> |